Jonathan Stauber

We invest in changemakers. Mission-driven startups. Ready to make an impact.

Charlie is a young Lille start-up born in 2020. The needs shared by many companies are : Its hard to have a real-time inventory of a stock of equipment, and also, unnecessary theft/buybacks that create duplicates material or the waste of time in searching the equipment are generating more and more costs. Our mission is to understand the environment and the needs of our customers to offer the best traceability system technologies to optimize their management system of the equipment.

APTEΞUS was created to provide clinicians and their patients suffering from orphan diseases, an innovative service of clinical biology that perfectly meets the emerging challenge of individualized medicine. APTEΞUS is engaged in patient-centric discovery of individualized treatments. Our technology allows the testing of thousands of molecules directly on primary cells sampled from patient with inborn error of metabolism. We can rapidly identify molecules that specifically correct the very molecular defect of the patient and give him a new opportunity to be cured.

Cell culture automation for R&D labs: Affordable, time-saving and easy to use. The Nestor automaton is a plug-and-play device able to culture cells in up to 10 flasks or multiwell plates. It is ultra-compact and portable, with a 2xA4 sheet footprint and a weight below 5 kg. Automate the most time consuming tasks in your cell culture processes, for an investment in the range of any other basic lab equipment (and get a return on your investment within 24 months only).

Hemerion is a clinical stage HealthTech company. Its first breakthrough technology jointly designed with University of Lille, Inserm and University Hospital of Lille, addresses brain cancer and aims to help patients in their fight against glioblastoma. Hemerion results of over 10 years of leading academic and clinical researches on innovative approaches to treat Glioblastoma. Today, Hemerion owns a unique and disruptive technology, already evaluated in frontline approach to treat patients harboring brain cancer.

We invest in changemakers. Mission-driven startups. Ready to make an impact.

50 Partners is a leading startup accelerator in France. Cofounded by 50 successful Tech entrepreneurs (BlaBlaCar, Showroomprivee, Le Bon Coin, …), the program provides a few selected startups with high quality mentoring, financing, international connections, networking and office space in central Paris. 50 Partners is a dedicated ecosystem for innovative tech projects, where entrepreneurs, VCs, corporates and industry experts are committed to help startups succeed

Charlie is a young Lille start-up born in 2020. The needs shared by many companies are : Its hard to have a real-time inventory of a stock of equipment, and also, unnecessary theft/buybacks that create duplicates material or the waste of time in searching the equipment are generating more and more costs. Our mission is to understand the environment and the needs of our customers to offer the best traceability system technologies to optimize their management system of the equipment.

APTEΞUS was created to provide clinicians and their patients suffering from orphan diseases, an innovative service of clinical biology that perfectly meets the emerging challenge of individualized medicine. APTEΞUS is engaged in patient-centric discovery of individualized treatments. Our technology allows the testing of thousands of molecules directly on primary cells sampled from patient with inborn error of metabolism. We can rapidly identify molecules that specifically correct the very molecular defect of the patient and give him a new opportunity to be cured.

Cell culture automation for R&D labs: Affordable, time-saving and easy to use. The Nestor automaton is a plug-and-play device able to culture cells in up to 10 flasks or multiwell plates. It is ultra-compact and portable, with a 2xA4 sheet footprint and a weight below 5 kg. Automate the most time consuming tasks in your cell culture processes, for an investment in the range of any other basic lab equipment (and get a return on your investment within 24 months only).